Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
|
BR |
Profarma Distribuidora de Produtos Farmaceuticos SA
Profarma Distribuidora de Produtos Farmaceuticos SA provides wholesale operations to pharmaceutical retailers, with the sale of medicines and health and beauty products. The company is headquartered in Rio De Janeiro, Rio De Janeiro. The company went IPO on 2006-10-26. The firm's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The firm's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Profarma Distribuidora de Produtos Farmaceuticos SA provides wholesale operations to pharmaceutical retailers, with the sale of medicines and health and beauty products. The company is headquartered in Rio De Janeiro, Rio De Janeiro. The company went IPO on 2006-10-26. The firm's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The firm's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Revenue Growth: Profarma’s net revenue grew by 14% year-on-year, with gross revenue reaching BRL 1.5 billion—up 15% from the previous year.
EBITDA Surge: EBITDA rose 35% year-on-year, totaling BRL 31.6 million this quarter, with notable strength in both Distribution (+42%) and Retail (+19%).
Cash Generation: Operating cash flow was positive for the second straight quarter, at BRL 24.7 million, a significant turnaround from last year’s negative figure.
Leverage Improvement: Net debt-to-EBITDA ratio dropped to 4x, the lowest since 2016, as the company maintained net debt levels despite revenue growth.
Margin Efficiency: Operating expenses fell to 12.6% of net revenue, the lowest since 2016, indicating greater efficiency.
Retail Strategy: Gross margin in Retail grew by 1.3 percentage points, with store portfolio optimization and selective expansion supporting performance.
No Formal Guidance: Management reiterated a long-term leverage target around 3x, but did not provide formal financial guidance.
